Clinical Trial Update: Assessing Changes in Gadoxetate Metabolism by the Liver Using MRI

View source ↗

Summary

This completed clinical trial evaluates changes in liver metabolism of the MRI contrast agent gadoxetate during MRI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Dysfunction

Drugs mentioned

• Gadoxetate disodium (Primovist/Eovist) (gadoxetate disodium)

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Liver Dysfunction | Status: COMPLETED